Skip to main content
SpringerLink
Log in

Paclitaxel-induced cutaneous toxicity

  • Short Communication
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Paclitaxel extravasation can induce moderate cutaneous toxicity, which resolves spontaneously in about 2 months.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ajani JA, Dodd LG, Daugherty K, Warkentin D, Ilson DH (1994) Taxolinduced soft-tissue injury secondary to extravasation: characterization by histopathology and clinical course. J Natl Cancer Inst 86:1

    Google Scholar 

  2. Bertelli G, Dini D, Forno G, Gozza A, Silvestro S, Venturini M, Pronzato P (1994) Local toxicity of antitumor chemotherapy: a study of possible antidotes. 6th International Symposium on Supportive Care in Cancer, New Orleans, La, 1994, P-12

  3. Lubejko BG, Sartorius SE (1993) Nursing considerations in paclitaxel (Taxol) administration. Semin Oncol 20 [Suppl 3]:26–30

    Google Scholar 

  4. Pazdur R, Kudelka AP, Kavanagh JJ, Cohen PR, Raber MN (1993) The taxoids: paclitaxel (Taxol) and docetaxel (Taxotere). Cancer Treat Rev 19:351–386

    Google Scholar 

  5. Raaf J (1994) Administration of chemotherapeutic agents. Techniques and controversies. Support Care Cancer 2:335–346

    Google Scholar 

  6. Rittenberg CN, Rehmeyer TA, Gralla RJ, Otten MC, Lang AB, Cronin MD, Bateman MM (1994) Reducing venous irritation in chemotherapy administration: an investigation during the new agent testing of Navelbine. 6th International Symposium on Supportive Care in Cancer, New Orleans, La, 1994, 0–11

  7. Rowinsky EK, Chaudhry V, Forastiere AA, Sartorius SE, Ettinger DS, Grochow LB, Lubejko BG, Cornblath DR, Donehower RC (1993) Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: neuromuscular toxicity is dose-limiting. J Clin Oncol 11:2010–2020

    Google Scholar 

  8. Rowinsky EK, Eisenhauer EA, Chaudhry V, Arbuck SG, Donehower RC (1993) Clinical toxicities encountered with paclitaxel (Taxol). Semin Oncol 20 [Suppl 3]:1–15

    Google Scholar 

  9. Strum SB (1994) Dimethylsulfoxide (DMSO) should be the standard of care in the treatment of extravasation injuries due to anti-neoplastics. 6th International Symposium on Supportive Care in Cancer, New Orleans, La, 1994, P-11

Download references

Author information

Authors and Affiliations

  1. Institut Jules Bordet, Centre des Tumeurs de l'Université Libre des Bruxelles, 1, Rue Héger-Bordet, B-1000, Brussels, Belgium

    T. Berghmans & J. Klastersky

Authors
  1. T. Berghmans
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Klastersky
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Berghmans, T., Klastersky, J. Paclitaxel-induced cutaneous toxicity. Support Care Cancer 3, 203–204 (1995). https://doi.org/10.1007/BF00368892

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00368892

Key words

Search

Navigation